MELISA Institute is the result of an academic initiative that brings together standard epidemiological research methods with advanced laboratory techniques of molecular biology.

A multidisciplinary team of researchers at MELISA Institute combines their knowledge and abilities to investigate determinants of maternal, embryonic and fetal health from an epidemiological and biological perspective.

MELISA Institute relies on different epidemiological designs and advanced multivariable statistical techniques to investigate factors influencing health and disease in different populations. We collect and analyze samples from a number of clinical trials, using cutting edge techniques in immunoassay, proteomics and genomics. Our aim is to develop innovative early diagnostic and therapeutic to improve or restore maternal, embryonic or fetal health from very early stages of pregnancy.

MELISA is an acronym that stands for Molecular Epidemiology for LIfe Science ReseArch. Our Institute carries out collaborative biomedical studies with researches from various universities, hospitals, clinics and laboratories.


Elard Koch, MPH PhD, is a molecular epidemiologist, doctorate in biomedical sciences from the University of Chile and currently director of research at the  MELISA Institute. He is also a postdoctoral researcher for the Women´s Research Program at the University of North Carolina.

Professor Koch developed a prolific career as a researcher and professor of clinical epidemiology at the Faculty of Medicine of the University of Chile for over 15 years, ultimately receiving the medal for academic excellence in research.

His work includes numerous publications in prestigious biomedical scientific  journals. Several of his scientific works have been recognized with various distinctions such as:  the Prize of the Medical Society of Chile, The Chilean Society of Cardiology and Cardiovascular Surgery, and the Henri Nestlé Prize among several others.